Tom Hamburger of the LATimes writes, "the pharmaceutical industry, once condemned by the president as a source of healthcare problems, has become a White House partner." Billy Tauzin, once a target for the President during his campaign has "Tauzin has morphed into the president's partner. He has been invited to the White House half a dozen times in recent months. There, he says, he eventually secured an agreement that the administration wouldn't try to overturn the very Medicare drug policy that Obama had criticized on the campaign trail."
Read the article, to find out more about how Tauzin is influencing the President's healthcare decisions.
Obama gives powerful drug lobby a seat at healthcare table
About Us
Health Care Insights - From Policy to Practice is the trusted source for news and commentary from the nation's leading Health Care Events such as Medicaid Drug Rebate Program Summit (MDRP), Medicaid Managed Care Congress (MMCC), FDA/CMS to inform Health Plans and Pharmaceutical Manufacturers on the latest developments on Medicare, Medicaid Managed Care, Government Programs, and Health Insurance Exchanges.
Topics we cover include reform, best business practices, the latest innovations, and novel payment models.
